Overview

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The aim is to investigate the best treatment regime of PEG-Intron A and lamivudine combination in terms of viral clearance in chronic hepatitis B patients.
Phase:
Phase 2
Details
Lead Sponsor:
Chinese University of Hong Kong
Collaborators:
GlaxoSmithKline
Hoffmann-La Roche
Treatments:
Interferons
Lamivudine